AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimkar-M 0.5 Tablet SR

Prescription Icon
Prescription Required

Marketer

Care Formulation Labs Pvt Ltd

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Glimkar-M 0.5 Tablet SR

Diabeticar Duo 0.5mg Extended Release tablets are antidiabetic medications combining two active ingredients for adult type 2 diabetes management. This dual-action formulation helps regulate blood glucose. Always take Diabeticar Duo 0.5mg ER with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Learn to recognize and treat these symptoms; regular meals and readily available fast-acting glucose sources (e.g., sugary foods, juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before using this medication if pregnant or breastfeeding. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended.

Primary Ingredients of Glimkar-M 0.5 Tablet SR

No text was provided to rewrite.

Uses of Glimkar-M 0.5 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimkar-M 0.5 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimkar-M 0.5mg Extended-Release tablet whole; do not crush, chew, or divide it. Administer this medication with food.

Common Side effects of Glimkar-M 0.5 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimkar-M 0.5 Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimkar-M 0.5 Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.

How Glimkar-M 0.5 Tablet SR works:

Glimkar-M 0.5 SR tablets contain glimepiride and metformin, two medications that manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimkar-M 0.5 Tablet SR and alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimkar-M 0.5 SR tablets during pregnancy might pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Consult your doctor for guidance.

Breast feedingBreast feedingUNSAFE

Extended-release Glimkar-M 0.5mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving may result from excessively high or low blood glucose levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimkar-M 0.5 Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. Glimkar-M 0.5 Tablet SR is contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimkar-M 0.5 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate hepatic dysfunction, Glimkar-M 0.5 Tablet SR therapy typically begins with a low dose; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Glimkar-M 0.5 Tablet SR :

Should you forget to take a Glimkar-M 0.5mg sustained-release tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimkar-M 0.5 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimkar-M 0.5 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimkar-M 0.5 Tablet SR can cause lactic acidosis (MALA), a serious medical emergency resulting from excessive blood lactic acid. This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimkar-M 0.5 Tablet SR and seek immediate medical attention.
Glimkar-M 0.5 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Glimkar-M 0.5 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimkar-M 0.5 Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimkar-M 0.5 Tablet SR can cause hypoglycemia (low blood sugar), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimkar-M 0.5 Tablet SR and alcohol is unsafe. This combination can dangerously lower blood sugar (causing hypoglycemia) and increase the risk of lactic acidosis.
Glimkar-M 0.5 Tablet SR
33
MRP 40
17% off